摘要
针对制药企业的工厂大数据安全性管理,结合中国药品生产质量管理规范(Good Manufacturing Practice of Medical Products,GMP)法规及数据安全法要求,从网络安全、设备数据使用情况、信息系统权限管理、数据完整性等方面,针对性分析工厂大数据完整性和安全性管理的现状和存在的问题,提出相应的解决方案,通过制订方案,实施策略,完善工厂大数据安全管理。
This study aims to explore how pharmaceutical factories can effectively manage big data security in accordance with Chinese Good Manufacturing Practice of Medical Products(GMP)regulations and data security law requirements.The research will conduct in-depth analysis from multiple dimensions such as network security,device data use,information system permission management and data integrity,aiming to find existing problems in the current management and protection of factory big data,propose corresponding solutions,and improve the security management of factory big data by formulating implementation strategies.
作者
刘洋
吴尚霖
陈永志
LIU Yang;WU Shanglin;CHEN Yongzhi(Chengdu Rongsheng Pharmaceuticals Co.,Ltd.,Chengdu Sichuan 610023,China)
出处
《信息与电脑》
2023年第15期212-214,共3页
Information & Computer
关键词
数据安全
制药企业
企业现状
实施策略
data security
Pharmaceutical company
current situation of enterprises
implementation strategy
